Jump to main content
Jump to site search

Issue 11, 2017
Previous Article Next Article

Design, synthesis and structure–activity relationships of (±)-isochaihulactone derivatives

Author affiliations

Abstract

Z-K8 (2), the racemic form of isochaihulactone (1), previously showed significant antitumor effects in A549 and LNCaP tumor-bearing mice. In the present study, 17 derivatives of 2 were designed, synthesized and evaluated for their anti-proliferative activity against four human tumor cell lines. All new derivatives exhibited high potency against A549 and P-glycoprotein (P-gp)-overexpressing KB-VIN. One of our new derivatives exhibited greater activity against three tested tumor cells (A549, KB, and KB-VIN) than 2, and induced cell cycle arrest in the G2/M phase. Moreover, SAR conclusions were first established for this series of compounds. Our study clearly identified a structural feature that should be retained for good activity and also a moiety that can tolerate various modifications and, thus, is ideal for further changes.

Graphical abstract: Design, synthesis and structure–activity relationships of (±)-isochaihulactone derivatives

Back to tab navigation

Publication details

The article was received on 21 Jun 2017, accepted on 15 Sep 2017 and first published on 12 Oct 2017


Article type: Research Article
DOI: 10.1039/C7MD00310B
Citation: Med. Chem. Commun., 2017,8, 2040-2049
  •   Request permissions

    Design, synthesis and structure–activity relationships of (±)-isochaihulactone derivatives

    Y. Zhao, P. Liu, K. Hsieh, P. Hsu, M. Goto, S. L. Morris-Natschke, H. Harn and K. Lee, Med. Chem. Commun., 2017, 8, 2040
    DOI: 10.1039/C7MD00310B

Search articles by author

Spotlight

Advertisements